logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Laurie H. Sehn

University of British Columbia

82H-index
658Paper Count
3.0WCitation Count
Published Papers 91
Publication Date
logo
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
errThe Lancet
IF97.3
err2025-12-05
err0
PREAI
errLaurie H Sehn; Kai Hübel; Stefano Luminari; Christian W Scholz; Antonio Salar; Shankara Paneesha; Björn Engelbrekt Wahlin; Panayiotis Panayiotidis; Hui-Peng Lee; Ana Jiménez-Ubieto; Juan-Manuel Sancho; Tae Min Kim; Eva Domingo Domenech; Takahiro Kumode; Christina Poh; Catherine Thieblemont; Dries Deeren; Edwin de Wit; Michael Arbushites; Irene Vassallo
errShare
errSave
Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy
errTransplantation and Cellular Therapy
IF4.4
err2025-11-08
err0
PREAI
errC. Arianne Buchan; Gerard Agbayani; Katrina Hueniken; Abi Vijenthira; Michael Sebag; Peng Wang; Lisa K. Hicks; Annette E. Hay; Sarit Assouline; Graeme Fraser; Amaris Balitsky; Joy Mangel; Carolyn Owen; Anthony Reiman; Laurie Sehn; Heather Sutherland; Tinghua Zhang; Corey Arnold; Allison M. Wilkin; Tamara Leite; Erinn McCarthy; Angela M Crawley; Marc-Andre Langlois; Christopher Bredeson; Natasha Kekre; David Allan; Curtis Cooper; Sita Bhella
errShare
errSave
Retreatment with R-CHOP-like Therapy in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma
errBlood Advances
IF7.1
err2025-11-01
err0
errOAAI
errJean-Nicolas Champagne; Diego Villa; Alina S. Gerrie; Christopher P. Venner; Graham W. Slack; Pedro Farinha; Jeffrey W. Craig; Laura K. Hilton; Kerry J. Savage; David W. Scott; Laurie H. Sehn
errShare
errSave
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology
errBlood Advances
IF7.1
err2025-10-17
err0
errOAAI
errWaleed Alduaij; Laurie H. Sehn; Jean-Nicolas Champagne; Brett Collinge; Susana Ben-Neriah; Aixiang Jiang; Laura K Hilton; Merrill Boyle; Barbara Meissner; Graham W. Slack; Pedro Farinha; Jeffrey W Craig; Kerry J. Savage; Diego Villa; Alina S. Gerrie; Ciara L. Freeman; Andrew J. Mungall; Christian Steidl; David W. Scott
errShare
errSave
Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?
errBlood
IF23.1
err2025-08-19
err0
PREAI
errCarla Casulo; Laurie H. Sehn
errShare
errSave
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
errBritish Journal of Haematology
IF3.8
err2025-07-30
err0
errOAAI
errAbi Vijenthira; Sita Bhella; Katrina Hueniken; Allison M. Wilkin; Michael Sebag; Peng Wang; Lisa K. Hicks; Annette E. Hay; Sarit Assouline; Amaris Balitsky; Graeme Fraser; Joy Mangel; Carolyn Owen; Anthony Reiman; Laurie Sehn; Heather Sutherland; Corey Arnold; Tamara Leite; Erinn McCarthy; Angela Crawley; Curtis Cooper; Marc-Andre Langlois; C. Arianne Buchan; VIP Study Investigators
errShare
errSave
Axicabtagene ciloleucel compared to standard of care in Canadian patients with relapsed or refractory large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial
errJOURNAL OF MEDICAL ECONOMICS
IF3
err2025-05-09
err0
errOAAI
errJohn Kuruvilla; Laurie H. Sehn; Sydney Whitney; Anik R. Patel; Heather Cameron; Geoffrey G. J. Reid
errShare
errSave
Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada
errcurrent oncology reports
IF3.4
err2025-02-28
err0
errOAAI
errFleury, Isabelle; Macdonald, David; Shafey, Mona; Christofides, Anna; Sehn, Laurie H.
errShare
errSave
Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)
errBLOOD
IF23.1
err2024-11-25
err3
PREAI
errSehn, Laurie H.; Luminari, Stefano; Scholz, Christian W.; Huebel, Kai; Salar, Antonio; Paneesha, Shankara; Wahlin, Bjorn E.; Panayiotidis, Panayiotis; Lee, Hui-Peng; Ubieto, Ana Jimenez; Sancho, Juan-Manuel; Kim, Tae Min; Domenech, Eva Domingo; Kumode, Takahiro; Poh, Christina; Thieblemont, Catherine; Deeren, Dries; de Wit, Edwin; Arbushites, Michael; Casadebaig, Marie-Laure; Trneny, Marek
errShare
errSave
Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBudde, Elizabeth; Matasar, Matthew; Sehn, Laurie H.; Assouline, Sarit E.; Kuruvilla, John; Flinn, Ian W.; Yoon, Sung-Soo; Bosch, Francesc; Greenwald, Daniel; Gutierrez, Norma C.; Tzachanis, Dimitrios; Marlton, Paula; Mcguirt, Delaney; Yin, Shen; Wei, Michael C.; Kwan, Antonia; Tracy, Samuel; Penuel, Elicia; Bartlett, Nancy L.
errShare
errSave
Retreatment with R-CHOP-like Therapy in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma (DLBCL)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChampagne, Jean-Nicolas; Villa, Diego; Gerrie, Alina S.; Venner, Christopher P.; Slack, Graham W.; Farinha, Pedro; Craig, Jeffrey W.; Hilton, Laura; Savage, Kerry J.; Scott, David W.; Sehn, Laurie H.
errShare
errSave
A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errShaalan, Haya; Frontzek, Fabian; Freeman, Ciare Louise; Lytle, Andrew; Farinha, Pedro; Alduaij, Waleed; Ben-Neriah, Susana; Boyle, Merrill; Meissner, Barbara; Weng, Andrew P.; Sehn, Laurie H.; Steidl, Christian; Hilton, Laura; Scott, David W.; Morin, Ryan
errShare
errSave
Richter Transformation (RT) in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Comparison of Two Eras
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChampagne, Jean-Nicolas; Huang, Steven; Ramadan, Rayan; Venner, Christopher P.; Ramadan, Khaled; Sehn, Laurie H.; Savage, Kerry J.; Villa, Diego; Scott, David W.; Alduaij, Waleed; Toze, Cynthia L.; Gerrie, Alina S.
errShare
errSave
Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥ 2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errShadman, Mazyar; Bartlett, Nancy L.; Matasar, Matthew; Schuster, Stephen J.; Assouline, Sarit E.; Sehn, Laurie H.; Kuruvilla, John; Giri, Pratyush; Cheah, Chan Y.; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Wei, Michael C.; Yin, Shen; Ma, Connie Y.; Tracy, Samuel; Kwan, Antonia; Penuel, Elicia; Budde, L. Elizabeth
errShare
errSave
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2024-06-05
err2
errOAAI
errSangha, Randeep; Jamal, Rahima; Spratlin, Jennifer; Kuruvilla, John; Sehn, Laurie H.; Beauchamp, Erwan; Weickert, Michael; Berthiaume, Luc G.; Mackey, John R.
errShare
errSave
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2024-04-15
err2
errOAAI
errDeng, Rong; Gibiansky, Leonid; Lu, Tong; Flowers, Christopher R.; Sehn, Laurie H.; Liu, Qi; Agarwal, Priya; Liao, Michael Z.; Dere, Randall; Lee, Calvin; Man, Gabriel; Hirata, Jamie; Li, Chunze; Miles, Dale
errShare
errSave
N-myristoylation inhibitor zelenirstat: New mechanistic insights and efficacy signals from a first in human phase I study
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errBerthiaume, Luc Gerard; Beauchamp, Erwan; Gamma, Jay; Pain, Rony; Kostiuk, Morris A.; Cromwell, Christopher R.; Moussa, Eman W.; Julien, Olivier; Hubbard, Basil P.; Kuruvilla, John; Sehn, Laurie H.; Spratlin, Jennifer; Jamal, Rahima; Sangha, Randeep; Mackey, John R.
errShare
errSave
High-plex imaging and cellular neighborhood spatial analysis reveals multiple immune escape and suppression patterns in diffuse large B-cell lymphoma
errLEUKEMIA
IF13.4
err2024-04-04
err0
errOAAI
errReiss, David J.; Nakayama, Yumi; Weng, Andrew P.; Stokes, Matthew E.; Sehn, Laurie; Steidl, Christian; Scott, David W.; Huang, C. Chris; Gandhi, Anita K.
errShare
errSave
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2024-02-08
err9
PREAI
errYousefirizi, Fereshteh; Klyuzhin, Ivan S.; Hyun, Joo; Harsini, Sara; Tie, Xin; Shiri, Isaac; Shin, Muheon; Lee, Changhee; Cho, Steve Y.; Bradshaw, Tyler J.; Zaidi, Habib; Benard, Francois; Sehn, Laurie H.; Savage, Kerry J.; Steidl, Christian; Uribe, Carlos F.; Rahmim, Arman
errShare
errSave
Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities
errSEMINARS IN HEMATOLOGY
IF4.1
err2023-11-01
err1
PREAI
errBrem, Elizabeth A.; Sehn, Laurie H.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
K
Kenneth C. Anderson
H-index: 199 · Papers: 3.1K
M
Marco A. Marra
H-index: 190 · Papers: 1.3K
R
Randy D. Gascoyne
H-index: 152 · Papers: 1.0K
L
Louis M. Staudt
H-index: 145 · Papers: 802
A
Andreas Rosenwald
H-index: 135 · Papers: 1.1K
View more